EUVIMEDEUVIMED entdecken
Crossref

The Prognostic Value of Preoperative C-Reactive Protein Levels in Resected Early-Stage Lung Cancer

Alberto Lopez-Pastorini, Zehra Tatli, Antonia von Bargen, Dennis Faltenberg, Hendrik Beling, Thomas Galetin, Aris Koryllos, Erich Stoelben

Journal of Surgical Research · 2025

DOI: 10.1016/j.jss.2024.11.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2025. Verfasst von Alberto Lopez-Pastorini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Cologne-Merheim Hospital, Witten/Herdecke University Hospital, Cologne, Germany; Faculty of Medicine, Witten/Herdecke…. Hauptthemen laut MEDLINE: C-Reactive Protein, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: C-reactive protein (CRP) is the most widely used marker of the systemic inflammatory response. An association between preoperative elevated levels and prognosis has been demonstrated for numerous tumors. The aim of this study was to investigate the association between preoperative CRP levels and survival in early-stage nonsmall cell lung cancer. METHODS: Data from 915 consecutive patients who underwent complete resection for stage I and II nonsmall cell lung cancer were retrospectively analyzed. Recurrence-free survival (RFS) and overall survival (OS) according to preoperative CRP levels were evaluated by the Kaplan-Meier method. The Cox proportional hazards model and logistic regression analysis were used for multivariate analysis. RESULTS: Five-year RFS and OS were 61.0% and 70.3% in the low CRP group (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinLung NeoplasmsCarcinoma, Non-Small-Cell LungBiomarkers, TumorHumansMaleFemaleMiddle AgedRetrospective StudiesAgedPrognosisAdultNeoplasm StagingPreoperative PeriodAged, 80 and overPneumonectomy

Stichwörter der Autor:innen

BiomarkersC-reactive proteinLung cancerPrognosis

Substanzen

C-Reactive ProteinBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Cologne-Merheim Hospital, Witten/Herdecke University Hospital, Cologne, Germany; Faculty of Medicine, Witten/Herdecke University, Witten, Germany. Electronic address: alberto.lopez-pastor…
  • Faculty of Medicine, University of Cologne, Cologne, Germany.
  • Faculty of Medicine, Witten/Herdecke University, Witten, Germany.
  • Department of Thoracic Surgery, Cologne-Merheim Hospital, Witten/Herdecke University Hospital, Cologne, Germany; Faculty of Medicine, Witten/Herdecke University, Witten, Germany.
  • Department of Thoracic Surgery, Cologne-Merheim Hospital, Witten/Herdecke University Hospital, Cologne, Germany; Faculty of Medicine, University of Cologne, Cologne, Germany.

Zitieren

APA

Lopez-Pastorini, A., Tatli, Z., von Bargen, A., Faltenberg, D., Beling, H., Galetin, T., Koryllos, A., & Stoelben, E. (2025). The Prognostic Value of Preoperative C-Reactive Protein Levels in Resected Early-Stage Lung Cancer. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2024.11.003

Vancouver

Lopez-Pastorini A, Tatli Z, von Bargen A, Faltenberg D, Beling H, Galetin T, et al. The Prognostic Value of Preoperative C-Reactive Protein Levels in Resected Early-Stage Lung Cancer. Journal of Surgical Research. 2025. doi:10.1016/j.jss.2024.11.003

BibTeX
@article{LopezPastorini2025,
  author = {Lopez-Pastorini, Alberto and Tatli, Zehra and von Bargen, Antonia and Faltenberg, Dennis and Beling, Hendrik and Galetin, Thomas and Koryllos, Aris and Stoelben, Erich},
  title = {The Prognostic Value of Preoperative C-Reactive Protein Levels in Resected Early-Stage Lung Cancer},
  journal = {Journal of Surgical Research},
  year = {2025},
  doi = {10.1016/j.jss.2024.11.003}
}
Kostenlos starten →